Interstitial lung disease in anti-MDA5 positive dermatomyositis

W Wu, L Guo, Y Fu, K Wang, D Zhang, W Xu… - Clinical reviews in …, 2021 - Springer
Anti-melanoma differentiation-associated gene 5–positive dermatomyositis (MDA5+ DM) is
a rare autoimmune disease predominantly reported in East Asia. MDA5+ DM is an …

Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: a systematic review

M McPherson, S Economidou, A Liampas, P Zis… - Seminars in Arthritis and …, 2022 - Elsevier
Introduction Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive
clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly …

[HTML][HTML] Tofacitinib in amyopathic dermatomyositis–associated interstitial lung disease

Z Chen, X Wang, S Ye - New England Journal of Medicine, 2019 - Mass Medical Soc
Amyopathic Dermatomyositis–Related Lung Disease The autoimmune disease amyopathic
dermatomyositis–associated interstitial lung disease, which is related to anti–melanoma …

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with …

SR Johnson, EJ Bernstein, MB Bolster… - Arthritis & …, 2024 - Wiley Online Library
Objective We provide evidence‐based recommendations regarding the treatment of
interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases …

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung …

F Romero-Bueno, PD Del Campo… - Seminars in arthritis and …, 2020 - Elsevier
Objectives The study aimed to develop evidence-based recommendations for the treatment
of rapidly progressive interstitial lung disease (RPILD) associated with the anti-Melanoma …

[HTML][HTML] Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations

T Shao, X Shi, S Yang, W Zhang, X Li, J Shu… - Frontiers in …, 2021 - frontiersin.org
Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …

[HTML][HTML] Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

P Mehta, PM Machado, L Gupta - Rheumatology International, 2021 - Springer
Abstract Anti-Melanoma Differentiation-Associated gene 5 (MDA-5) Dermatomyositis
(MDA5, DM) is a recently identified subtype of myositis characteristically associated with …

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

BF Collins, G Raghu - European Respiratory Review, 2019 - Eur Respiratory Soc
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …

2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

Y Kondoh, S Makino, T Ogura, T Suda, H Tomioka… - Respiratory …, 2021 - Elsevier
The prognosis of patients with connective tissue disease (CTD) has improved significantly in
recent years, but interstitial lung disease (ILD) associated with connective tissue disease …

[HTML][HTML] Diagnosis and management of myositis-associated lung disease

RW Hallowell, SK Danoff - Chest, 2023 - Elsevier
Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …